Health Canada Approves Updates to TYSABRI (natalizumab) Product Monograph to ... PR Newswire (press release) The new label identifies anti-JC virus (JCV) antibody status as a risk factor for developing an uncommon, but serious, brain infection known as progressive multifocal leukoencephalopathy (PML). This marks the third risk factor identified to help ... Biogen Says Health Canada Approves Updates To TYSABRI Product Monograph The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers ... |
Read More... [Source: virus - Google News - Posted by FreeAutoBlogger]
No comments:
Post a Comment